IL2 and colorectal carcinoma: In summary, we have been able to transduce PBMC-derived T cells with a novel anti-Hsp70 CAR and thereby enable them to recognize CRC cells expressing mHsp70 in a way that resembles the specificity and cytolytic activity of TKD/IL-2 activated NK cells.